Vitamin D signaling in the bovine immune system: A model for understanding human vitamin D requirements

Nutrients

Volumn 4, Issue 3, 2012, Pages 181-196

  Nelson, Corwin D ^a   Reinhardt, Timothy A ^b   Lippolis, John D ^b   Sacco, Randy E ^b   Nonnecke, Brian J ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b NATIONAL ANIMAL DISEASE CENTER   (United States)

Author keywords

Animal models; Cattle; Immunity; Vitamin D

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CATHELICIDIN; CD14 ANTIGEN; CYTOCHROME P450; CYTOCHROME P450 CYP24A1; CYTOCHROME P450 CYP27B1; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 8; NITRIC OXIDE; RANTES; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; CALCIUM HOMEOSTASIS; CD4+ T LYMPHOCYTE; CELL FUNCTION; COW; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; KERATINOCYTE; MACROPHAGE; MASTITIS; MONOCYTE; NONHUMAN; NUTRITIONAL REQUIREMENT; PROMOTER REGION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; UPREGULATION; VITAMIN D METABOLISM; VITAMIN INTAKE;

ANIMALIA; BOS; BOVINAE;

EID: 84858962056     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu4030181     Document Type: Review

References (96)

1. Horst, R.L.; Goff, J.P.; Reinhardt, T.A. Calcium and vitamin D metabolism in the dairy cow. J. Dairy Sci. 1994, 77, 1936-1951.
2. Horst, R.L.; Goff, J.P.; Reinhardt, T.A. Calcium and vitamin D metabolism during lactation. J. Mammary Gland Biol. Neoplasia 1997, 2, 253-263.
3. Horst, R.L.; Goff, J.P.; Reinhardt, T.A. Role of vitamin D in calcium homeostasis and its use in prevention of bovine periparturient paresis. Acta Vet. Scand. Suppl. 2003, 97, 35-50.
4. Horst, R.L.; Goff, J.P.; Reinhardt, T.A. Adapting to the transition between gestation and lactation: Differences between rat, human and dairy cow. J. Mammary Gland Biol. Neoplasia 2005, 10, 141-156.
5. Horst, R.L.; Reinhardt, T.A. Vitamin D metabolism in ruminants and its relevance to the periparturient cow. J. Dairy Sci. 1983, 66, 661-678.
6. NRC. Nutrient Requirements of Dairy Cattle: Seventh Revised Edition; National Academy of Sciences: Washington, DC, USA, 2001.
7. Hidiroglou, M.; Williams, C.J.; Proulx, J.G. Plasma vitamin D3 response in cattle and sheep exposed to ultraviolet radiation. Int. J. Vitam. Nutr. Res. 1985, 55, 41-46.
8. Hymoller, L.; Jensen, S.K. Vitamin D3 synthesis in the entire skin surface of dairy cows despite hair coverage. J. Dairy Sci. 2010, 93, 2025-2029.
9. Hymoller, L.; Jensen, S.K.; Lindqvist, H.; Johansson, B.; Nielsen, M.O.; Nadeau, E. Supplementing dairy steers and organically managed dairy cows with synthetic vitamin D3 is unnecessary at pasture during exposure to summer sunlight. J. Dairy Res. 2009, 76, 372-378.
10. Weiss, W.P. Requirements of fat-soluble vitamins for dairy cows: A review. J. Dairy Sci. 1998, 81, 2493-2501.
11. Lippolis, J.D.; Reinhardt, T.A. Ruminant Diseases and Immunology Research Unit, National Animal Disease Center, United States Department of Agriculture, Agricultural Research Service, Ames, IA, USA. Unpublished work, 2012.
12. Lippolis, J.D.; Reinhardt, T.A.; Sacco, R.A.; Nonnecke, B.J.; Nelson, C.D. Treatment of an intramammary bacterial infection with 25-hydroxyvitamin D3. PLoS One 2011, 6.doi:10.1371/ journal.pone.0025479.
13. Nelson, C.D.; Nonnecke, B.J.; Reinhardt, T.A.; Waters, W.R.; Beitz, D.C.; Lippolis, J.D. Regulation of Mycobacterium-specific mononuclear cell responses by 25-hydroxyvitamin D3. PLoS One 2011, 6.doi:10.1371/journal.pone.0021674.
14. Nelson, C.D.; Reinhardt, T.A.; Beitz, D.C.; Lippolis, J.D. In vivo activation of the intracrine vitamin D pathway in innate immune cells and mammary tissue during a bacterial infection. PLoS One 2010, 5. doi:10.1371/journal.pone.0015469.
15. Nelson, C.D.; Reinhardt, T.A.; Thacker, T.C.; Beitz, D.C.; Lippolis, J.D. Modulation of the bovine innate immune response by production of 1alpha,25-dihydroxyvitamin D3 in bovine monocytes. J. Dairy Sci. 2010, 93, 1041-1049.
16. Dietary Reference Intakes for Calcium and Vitamin D; Ross, A.C., Taylor, C.L., Yaktine, A.L., del Valle, H.B., Eds.; The National Academies Press: Washington, DC, USA, 2011.
17. Ametaj, B.N.; Beitz, D.C.; Reinhardt, T.A.; Nonnecke, B.J. 1,25-Dihydroxyvitamin D3 inhibits secretion of interferon-gamma by mitogen- and antigen-stimulated bovine mononuclear leukocytes. Vet. Immunol. Immunopathol. 1996, 52, 77-90.
18. Nonnecke, B.J.; Franklin, S.T.; Reinhardt, T.A.; Horst, R.L. In vitro modulation of proliferation and phenotype of resting and mitogen-stimulated bovine mononuclear leukocytes by 1,25-dihydroxyvitamin D3. Vet. Immunol. Immunopathol. 1993, 38, 75-89.
19. Nonnecke, B.J.; Waters, W.R.; Foote, M.R.; Horst, R.L.; Fowler, M.A.; Miller, B.L. In vitro effects of 1,25-dihydroxyvitamin D3 on interferon-gamma and tumor necrosis factor-alpha secretion by blood leukocytes from young and adult cattle vaccinated with Mycobacterium bovis BCG. Int. J. Vitam. Nutr. Res. 2003, 73, 235-244.
20. Waters, W.R.; Nonnecke, B.J.; Foote, M.R.; Maue, A.C.; Rahner, T.E.; Palmer, M.V.; Whipple, D.L.; Horst, R.L.; Estes, D.M. Mycobacterium bovis bacille Calmette-Guerin vaccination of cattle: Activation of bovine CD4+ and gamma delta TCR+ cells and modulation by 1,25-dihydroxyvitamin D3. Tuberculosis (Edinb.) 2003, 83, 287-297.
21. Waters, W.R.; Nonnecke, B.J.; Rahner, T.E.; Palmer, M.V.; Whipple, D.L.; Horst, R.L. Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D3. Clin. Diagn. Lab. Immunol. 2001, 8, 1204-1212.
22. Hewison, M. Vitamin D and the intracrinology of innate immunity. Mol. Cell. Endocrinol. 2010, 321, 103-111.
23. Liu, P.T.; Stenger, S.; Li, H.; Wenzel, L.; Tan, B.H.; Krutzik, S.R.; Ochoa, M.T.; Schauber, J.; Wu, K.; Meinken, C. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311, 1770-1773.
24. Stoffels, K.; Overbergh, L.; Bouillon, R.; Mathieu, C. Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: Unravelling the IFNgamma pathway. J. Steroid Biochem. Mol. Biol. 2007, 103, 567-571.
25. Gombart, A.F.; Borregaard, N.; Koeffler, H.P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 2005, 19, 1067-1077.
26. Wang, T.T.; Nestel, F.P.; Bourdeau, V.; Naga, I.Y.; Wang, Q.; Liao, J.; Tavera-Mendoza, L.; Lin, R.; Hanrahan, J.W.; Mader, S. et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004, 173, 2909-2912.
27. Gombart, A.F.; Saito, T.; Koeffler, H.P. Exapation of an ancient Alu short interspesed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates. BMC Genomics 2009, 10.doi:10.1186/1471-2164-10-321.
28. Schauber, J.; Dorschner, R.A.; Coda, A.B.; Buchau, A.S.; Liu, P.T.; Kiken, D.; Helfrich, Y.R.; Kang, S.; Elalieh, H.Z.; Steinmeyer, A. et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J. Clin. Invest. 2007, 117, 803-811.
29. Wang, T.T.; Tavera-Mendoza, L.E.; Laperriere, D.; Libby, E.; MacLeod, N.B.; Nagai, Y.; Bourdeau, V.; Konstorum, A.; Lallemant, B.; Zhang, R. et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol. Endocrinol. 2005, 19, 2685-2695.
30. Nelson, C.D.; Reinhardt, T.A.; Lippolis, J.D. Ruminant Diseases of Immunology Research Unit, National Animal Disease Center, United States Department of Agriculture, Agricultural Research Service, Ames, IA, USA. Unpublished work, 2012.
31. Liu, P.T.; Schenk, M.; Walker, V.P.; Dempsey, P.W.; Kanchanapoomi, M.; Wheelwright, M.; Vazirnia, A.; Zhang, X.; Steinmeyer, A.; Zugel, U. et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 2009, 4. doi:10.1371/journal.pone.0005810.
32. Martineau, A.R.; Wilkinson, K.A.; Newton, S.M.; Floto, R.A.; Norman, A.W.; Skolimowska, K.; Davidson, R.N.; Sorensen, O.E.; Kampmann, B.; Griffiths, C. J. et al. IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: The role of cathelicidin LL-37. J. Immunol. 2007, 178, 7190-7198.
33. Rockett, K.A.; Brookes, R.; Udalova, I.; Vidal, V.; Hill, A.V.; Kwiatkowski, D. 1,25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect. Immun. 1998, 66, 5314-5321.
34. Chang, J.M.; Kuo, M.C.; Kuo, H.T.; Hwang, S.J.; Tsai, J.C.; Chen, H.C.; Lai, Y.H. 1-alpha,25-Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells. J. Lab. Clin. Med. 2004, 143, 14-22.
35. Wang, T.T.; Dabbas, B.; Laperriere, D.; Bitton, A.J.; Soualhine, H.; Tavera-Mendoza, L.E.; Dionne, S.; Servant, M.J.; Bitton, A.; Seidman, E.G. et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J. Biol. Chem. 2010, 285, 2227-2231.
36. Lemire, J.M.; Adams, J.S.; Sakai, R.; Jordan, S.C. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Invest. 1984, 74, 657-661.
37. Bhalla, A.K.; Amento, E.P.; Serog, B.; Glimcher, L.H. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J. Immunol. 1984, 133, 1748-1754.
38. Koizumi, T.; Nakao, Y.; Matsui, T.; Nakagawa, T.; Katakami, Y.; Fujita, T. Effect of 1,25-dihydroxyvitamin D3 on cytokine-induced thymocyte proliferation. Cell. Immunol. 1985, 96, 455-461.
39. Baeke, F.; Korf, H.; Overbergh, L.; van Etten, E.; Verstuyf, A.; Gysemans, C.; Mathieu, C. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system. J. Steroid Biochem. Mol. Biol. 2010, 121, 221-227.
40. Jeffery, L.E.; Burke, F.; Mura, M.; Zheng, Y.; Qureshi, O.S.; Hewison, M.; Walker, L.S.; Lammas, D.A.; Raza, K.; Sansom, D.M. 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J. Immunol. 2009, 183, 5458-5467.
41. Tang, J.; Zhou, R.; Luger, D.; Zhu, W.; Silver, P.B.; Grajewski, R.S.; Su, S.B.; Chan, C.C.; Adorini, L.; Caspi, R.R. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J. Immunol. 2009, 182, 4624-4632.
42. Chang, S.H.; Chung, Y.; Dong, C. Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J. Biol. Chem. 2010, 285, 38751-38755.
43. Heine, G.; Niesner, U.; Chang, H.D.; Steinmeyer, A.; Zugel, U.; Zuberbier, T.; Radbruch, A.; Worm, M. 1,25-dihydroxyvitamin D3 promotes IL-10 production in human B cells. Eur. J. Immunol. 2008, 38, 2210-2218.
44. Gambhir, V.; Kim, J.; Siddiqui, S.; Taylor, M.; Byford, V.; Petrof, E.O.; Jones, G.; Basta, S. Influence of 1,25-dihydroxy vitamin D3 on TLR4-induced activation of antigen presenting cells is dependent on the order of receptor engagement. Immunobiology 2011, 216, 988-996.
45. Palmer, M.T.; Lee, Y.K.; Maynard, C.L.; Oliver, J.R.; Bikle, D.D.; Jetten, A.M.; Weaver, C.T. Lineage-specific effects of 1,25-dihydroxyvitamin D3 on the development of effector CD4 T cells. J. Biol. Chem. 2011, 286, 997-1004.
46. Chang, J.H.; Cha, H.R.; Lee, D.S.; Seo, K.Y.; Kweon, M.N. 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 2010, 5. doi:10.1371/journal.pone.0012925.
47. Waters, W.R.; Palmer, M.V.; Nonnecke, B.J.; Whipple, D.L.; Horst, R.L. Mycobacterium bovis infection of vitamin D-deficient NOS2-/- mice. Microb. Pathog. 2004, 36, 11-17.
48. Thoma-Uszynski, S.; Stenger, S.; Takeuchi, O.; Ochoa, M.T.; Engele, M.; Sieling, P.A.; Barnes, P.F.; Rollinghoff, M.; Bolcskei, P.L.; Wagner, M. et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 2001, 291, 1544-1547.
49. Bogdan, C. Nitric oxide and the immune response. Nat. Immunol. 2001, 2, 907-916.
50. Lacasse, P.; Farr, V.C.; Davis, S.R.; Prosser, C.G. Local secretion of nitric oxide and the control of mammary blood flow. J. Dairy Sci. 1996, 79, 1369-1374.
51. Levy, J.A. The unexpected pleiotropic activities of RANTES. J. Immunol. 2009, 182, 3945-3946.
52. Elsik, C.G.; Tellam, R.L.; Worley, K.C.; Gibbs, R.A.; Muzny, D.M.; Weinstock, G.M.; Adelson, D.L.; Eichler, E.E.; Elnitski, L.; Guigo, R. et al. The genome sequence of taurine cattle: A window to ruminant biology and evolution. Science 2009, 324, 522-528.
53. Bettelli, E.; Korn, T.; Kuchroo, V.K. Th17: The third member of the effector T cell trilogy. Curr. Opin. Immunol. 2007, 19, 652-657.
54. Plattner, B.L.; Hostetter, J.M. Comparative gamma delta T cell immunology: A focus on mycobacterial disease in cattle. Vet. Med. Int. 2011, 2011, 214384.
55. Baldwin, C.L.; Sathiyaseelan, T.; Naiman, B.; White, A.M.; Brown, R.; Blumerman, S.; Rogers, A.; Black, S.J. Activation of bovine peripheral blood gammadelta T cells for cell division and IFN-gamma production. Vet. Immunol. Immunopathol. 2002, 87, 251-259.
56. Martin, B.; Hirota, K.; Cua, D.J.; Stockinger, B.; Veldhoen, M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31, 321-330.
57. O'Brien, R.L.; Roark, C.L.; Born, W.K. IL-17-producing gammadelta T cells. Eur. J. Immunol. 2009, 39, 662-666.
58. Cantorna, M.T.; Hayes, C.E.; DeLuca, H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 1996, 93, 7861-7864.
59. Cantorna, M.T.; Hayes, C.E.; DeLuca, H.F. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J. Nutr. 1998, 128, 68-72.
60. Cantorna, M.T.; Munsick, C.; Bemiss, C.; Mahon, B.D. 1,25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J. Nutr. 2000, 130, 2648-2652.
61. Cantorna, M.T. Mechanisms underlying the effect of vitamin D on the immune system. Proc. Nutr. Soc. 2010, 69, 286-289.
62. Hayes, C.E.; Nashold, F.E.; Mayne, C.G.; Spanier, J.A.; Nelson, C.D. Vitamin D and Multiple Sclerosis. In Vitamin D, 3rd ed.; Feldman, D., Pike, J.W., Adams, J.S., Eds.; Elsevier: San Diego, CA, USA, 2011.
63. Vordermeier, H.M.; Chambers, M.A.; Cockle, P.J.; Whelan, A.O.; Simmons, J.; Hewinson, R.G. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect. Immun. 2002, 70, 3026-3032.
64. Vordermeier, H.M.; Villarreal-Ramos, B.; Cockle, P.J.; McAulay, M.; Rhodes, S.G.; Thacker, T.; Gilbert, S.C.; McShane, H.; Hill, A.V.; Xing, Z. et al. Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect. Immun. 2009, 77, 3364-3373.
65. Fabri, M.; Stenger, S.; Shin, D.M.; Yuk, J.M.; Liu, P.T.; Realegeno, S.; Lee, H.M.; Krutzik, S.R.; Schenk, M.; Sieling, P.A. et al. Vitamin D is required for IFN-γ-mediated antimicrobial activity of human macrophages. Sci. Transl. Med. 2011, 3. doi:10.1126/scitranslmed.3003045.
66. Adams, J.S.; Sharma, O.P.; Gacad, M.A.; Singer, F.R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J. Clin. Invest. 1983, 72, 1856-1860.
67. Stoffels, K.; Overbergh, L.; Giulietti, A.; Verlinden, L.; Bouillon, R.; Mathieu, C. Immune regulation of 25-hydroxyvitamin-D3-1α-hydroxylase in human monocytes. J. Bone Miner. Res. 2006, 21, 37-47.
68. Schuster, I.; Egger, H.; Bikle, D.; Herzig, G.; Reddy, G.S.; Stuetz, A.; Stuetz, P.; Vorisek, G. Selective inhibition of vitamin D hydroxylases in human keratinocytes. Steroids 2001, 66, 409-422.
69. Chen, S.; Sims, G.P.; Chen, X.X.; Gu, Y.Y.; Lipsky, P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 2007, 179, 1634-1647.
70. Enioutina, E.Y.; Bareyan, D.; Daynes, R.A. TLR-induced local metabolism of vitamin D3 plays an important role in the diversification of adaptive immune responses. J. Immunol. 2009, 182, 4296-4305.
71. Rainard, P.; Riollet, C. Innate immunity of the bovine mammary gland. Vet. Res. 2006, 37, 369-400.
72. Kemmis, C.M.; Salvador, S.M.; Smith, K.M.; Welsh, J. Human mammary epithelial cells express CYP27B1 and are growth inhibited by 25-Hydroxyvitamin D-3, the major circulating form of vitamin D-3. J. Nutr. 2006, 136, 887-892.
73. Rowling, M.J.; Kemmis, C.M.; Taffany, D.A.; Welsh, J. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J. Nutr. 2006, 136, 2754-2759.
74. McDermott, C.M.; Beitz, D.C.; Littledike, E.T.; Horst, R.L. Effects of dietary vitamin D3 on concentrations of vitamin D and its metabolites in blood plasma and milk of dairy cows. J. Dairy Sci. 1985, 68, 1959-1967.
75. Hollis, B.W.; Roos, B.A.; Draper, H.H.; Lambert, P.W. Vitamin D and its metabolites in human and bovine milk. J. Nutr. 1981, 111, 1240-1248.
76. Nonnecke, B.J.; Reinhardt, T.A.; Sacco, R.E.; Waters, W.R. Ruminant Diseases of Immunology Research Unit, National Animal Disease Center, United States Department of Agriculture, Agricultural Research Service, Ames, IA, USA. Unpublished work, 2012.
77. Sacco, R.E.; Nonnecke, B.J.; Palmer, M.V.; Waters, W.R.; Lippolis, J.D.; Reinhardt, T.A. Differential expression of cytokines in response to respiratory syncytial virus infection of calves with high or low circulating 25-hydroxyvitamin D3. PLoS One 2012, 7. doi:10.1371/journal.pone.0033074.
78. Vieth, R. Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/mL). Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25, 681-691.
79. Hollis, B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: Implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 2005, 135, 317-322.
80. Wagner, C.L.; Taylor, S.N.; Hollis, B.W. Does vitamin D make the world go "round"? Breastfeed. Med. 2008, 3, 239-250.
81. Burton, J.M.; Kimball, S.; Vieth, R.; Bar-Or, A.; Dosch, H.M.; Cheung, R.; Gagne, D.; D'Souza, C.; Ursell, M.; O'Connor, P. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010, 74, 1852-1859.
82. Ginde, A.A.; Mansbach, J.M.; Camargo, C.A., Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2009, 169, 384-390.
83. Ginde, A.A.; Mansbach, J.M.; Camargo, C.A., Jr. Vitamin D, respiratory infections, and asthma. Curr. Allergy Asthma Rep. 2009, 9, 81-87.
84. Smolders, J.; Menheere, P.; Kessels, A.; Damoiseaux, J.; Hupperts, R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult. Scler. 2008, 14, 1220-1224.
85. Urashima, M.; Segawa, T.; Okazaki, M.; Kurihara, M.; Wada, Y.; Ida, H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am. J. Clin. Nutr. 2010, 91. doi: 10.3945/ajcn.2009.29094.
86. Martineau, A.R.; Nhamoyebonde, S.; Oni, T.; Rangaka, M.X.; Marais, S.; Bangani, N.; Tsekela, R.; Bashe, L.; de Azevedo, V.; Caldwell, J. et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc. Natl. Acad. Sci. USA 2011, 108. doi:10.1073/pnas.1111825108.
87. Adams, J.S.; Hewison, M. Update in vitamin D. J. Clin. Endocrinol. Metab. 2010, 95, 471-478.
88. Heaney, R.P.; Holick, M.F. Why the IOM recommendations for vitamin D are deficient. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2011, 26, 455-457.
89. Engstrom, G.W.; Goff, J.P.; Horst, R.L.; Reinhardt, T.A. Regulation of calf renal 25- ydroxyvitamin D-hydroxylase activities by calcium-regulating hormones. J. Dairy Sci. 1987, 70, 2266-2271.
90. Littledike, E.T.; Horst, R.L. Vitamin D3 toxicity in dairy cows. J. Dairy Sci. 1982, 65, 749-759.
91. Nonnecke, B.J.; Foote, M.R.; Miller, B.L.; Beitz, D.C.; Horst, R.L. Short communication: Fat-soluble vitamin and mineral status of milk replacer-fed dairy calves: Effect of growth rate during the preruminant period. J. Dairy Sci. 2010, 93, 2684-2690.
92. Nonnecke, B.J.; Reinhardt, T.A.; Waters, W.R. Short communication: The preruminant calf as a model for characterizing the effects of vitamin D status in the neonate. J. Dairy Sci. 2009, 92, 5692-5696.
93. Endsley, J.J.; Waters, W.R.; Palmer, M.V.; Nonnecke, B.J.; Thacker, T.C.; Jacobs, W.R., Jr.; Larsen, M.H.; Hogg, A.; Shell, E.; McAlauy, M. et al. The calf model of immunity for development of a vaccine against tuberculosis. Vet. Immunol. Immunopathol. 2009, 128, 199-204.
94. Van Rhijn, I.; Godfroid, J.; Michel, A.; Rutten, V. Bovine tuberculosis as a model for human tuberculosis: Advantages over small animal models. Microb. Infect. 2008, 10, 711-715.
95. Bem, R.A.; Domachowske, J.B.; Rosenberg, H.F. Animal models of human respiratory syncytial virus disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301, L148-L156.
96. Meyer, G.; Deplanche, M.; Schelcher, F. Human and bovine respiratory syncytial virus vaccine research and development. Comp. Immunol. Microbiol. Infect. Dis. 2008, 31, 191-225.